Eplivanserin (hemifumarate)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Eplivanserin (hemifumarate)
Description:
Eplivanserin (SR-46349) hemifumarate is a potent, selective and orally active 5-HT2A receptor antagonist, with an IC50 of 5.8 nM in rat cortical membrane, and a Kd of 1.14 nM. Eplivanserin hemifumarate displays >20-fold selectivity more selective for 5-HT2A than 5-HT2B and 5-HT2C[1][2].Product Name Alternative:
SR-46349 (hemifumarate) ; SR 46349BUNSPSC:
12352005Hazard Statement:
H302, H410Target:
5-HT ReceptorType:
Reference compoundRelated Pathways:
GPCR/G Protein; Neuronal SignalingApplications:
Neuroscience-NeuromodulationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/eplivanserin-hemifumarate.htmlPurity:
99.10Solubility:
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
O=C(O)/C=C/C(O)=O.OC(C=C1)=CC=C1/C=C/C(C2=C(C=CC=C2)F)=N/OCCN(C)C.[1/2]Molecular Formula:
C19H21FN2O2.1/2C4H4O4Molecular Weight:
386.43Precautions:
H302, H410References & Citations:
[1]Rinaldi-Carmona M, et al. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther. 1992 Aug;262 (2) :759-68.|[2]Malgorzata Filip, et al. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther. 2004 Sep;310 (3) :1246-54.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
Phase 3Isoform:
5-HT2 Receptor; α-1 microglobulinCAS Number:
[130580-02-8]
